Upstream Position of Proline Defines Peptide-HLA Class I Repertoire Formation and CD8+ T Cell Responses.
Ayumi HongoTakayuki KanasekiSerina TokitaVitaly KochinSho MiyamotoYuiko HashinoAmy CoddNoriko KawaiMunehide NakatsugawaYoshihiko HirohashiNoriyuki SatoToshihiko TorigoePublished in: Journal of immunology (Baltimore, Md. : 1950) (2019)
Cytotoxic CD8+ T lymphocytes (CTLs) recognize peptides displayed by HLA class I molecules on cell surfaces, monitoring pathological conditions such as cancer. Difficulty in predicting HLA class I ligands is attributed to the complexity of the Ag processing pathway across the cytosol and the endoplasmic reticulum. By means of HLA ligandome analysis using mass spectrometry, we collected natural HLA class I ligands on a large scale and analyzed the source-protein sequences flanking the ligands. This comprehensive analysis revealed that the frequency of proline at amino acid positions 1-3 upstream of the ligands was selectively decreased. The depleted proline signature was the strongest among all the upstream and downstream profiles. Experiments using live cells demonstrated that the presence of proline at upstream positions 1-3 attenuated CTL responses against a model epitope. Other experiments, in which N-terminal-flanking Ag precursors were confined in the endoplasmic reticulum, demonstrated an inability to remove upstream prolines regardless of their positions, suggesting a need for synergistic action across cellular compartments for making the proline signature. Our results highlight, to our knowledge, a unique role and position of proline for inhibiting downstream epitope presentation, which provides a rule for defining natural peptide-HLA class I repertoire formation and CTL responses.
Keyphrases
- endoplasmic reticulum
- amino acid
- mass spectrometry
- quantum dots
- single cell
- stem cells
- signaling pathway
- oxidative stress
- liquid chromatography
- escherichia coli
- mesenchymal stem cells
- young adults
- cell therapy
- cell cycle arrest
- bone marrow
- cell death
- cancer therapy
- biofilm formation
- drug delivery
- monoclonal antibody
- pseudomonas aeruginosa
- high performance liquid chromatography
- capillary electrophoresis
- genetic diversity
- childhood cancer
- endoplasmic reticulum stress